Consistent with previous studies, Kaplan-Meier analysis demonstrated that patients with CRC with high FABP4 expression exhibited a lower survival rate, suggesting that FABP4 is a potential risk factor for CRC. Here, FABP4 is linked to colorectal carcinoma.